GE HealthCare Technologies debt and dilution42

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

$10,095M

Cash & equivalents

USD millions

$2,079M

Net debt

USD millions

$8,016M

Debt / equity

0.92×

Debt / assets

27.1%

Net debt / EBITDA

× · TTM

2.4×

Debt / FCF

× · TTM

—

Interest coverage

× · TTM

6.42×

Current ratio

1.26×

Diluted shares

Million shares

454M shares

Basic shares

Million shares

453M shares

Share count growth

-0.88%

Share repurchases

USD millions

$200M

Quarterly data

GE HealthCare Technologies capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q2	Jun 30, 2026	10,095	2,079	8,016	0.92×	27.1%	2.4×	—	6.42×	1.26×	454	453	-0.88%	200
FY 2026 Q1	Mar 31, 2026	10,136	2,261	7,875	0.95×	27.3%	2.43×	—	6.23×	1.22×	457	456	-0.22%	100
FY 2025 Q4	Dec 31, 2025	10,505	4,492	6,013	1.01×	28.46%	1.8×	6.98×	6.28×	1.37×	458	453.03	-0.65%	0
FY 2025 Q3	Sep 30, 2025	12,284	4,005	8,279	1.23×	34%	2.5×	8.77×	6.02×	1.18×	457	456	-0.22%	100
FY 2025 Q2	Jun 30, 2025	12,277	3,737	8,540	1.26×	34.58%	2.57×	—	5.82×	1.16×	458	457	0%	100
FY 2025 Q1	Mar 31, 2025	10,759	2,454	8,305	1.17×	32.03%	2.53×	—	5.52×	0.98×	459	457	0.22%	0
FY 2024 Q4	Dec 31, 2024	10,451	2,874	7,577	1.23×	31.58%	2.36×	6.73×	5.21×	1.04×	459	456	0.22%	0
FY 2024 Q3	Sep 30, 2024	11,317	3,550	7,767	1.36×	33.43%	2.51×	—	4.89×	1.23×	459	457	0.44%	0
FY 2024 Q2	Jun 30, 2024	10,243	1,997	8,246	1.31×	32.16%	2.7×	6.33×	4.7×	1.06×	459	457	0.44%	—
FY 2024 Q1	Mar 31, 2024	10,258	2,551	7,707	1.38×	31.85%	2.55×	6.17×	4.58×	1.06×	459	456	0.44%	—
FY 2023 Q4	Dec 31, 2023	10,444	2,494	7,950	1.46×	32.18%	2.61×	6.09×	4.49×	1.05×	458	455	—	—
FY 2023 Q3	Sep 30, 2023	10,267	2,408	7,859	1.44×	31.71%	—	—	—	1.25×	458	455	—	—
FY 2023 Q2	Jun 30, 2023	10,243	1,936	8,307	1.44×	31.7%	—	—	—	1.22×	458	455	—	—
FY 2023 Q1	Mar 31, 2023	10,244	2,324	7,920	1.53×	31.39%	—	—	—	1.17×	457	454	—	—

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · GEHC, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.